Abstract
An agent that clears disease-associated amyloid aggregates from the brains of patients with Alzheimer's disease does not alleviate disease progression. Yet this disappointing news should not rule out such potential therapies.
Original language | English |
---|---|
Pages (from-to) | 418-420 |
Number of pages | 3 |
Journal | Nature |
Volume | 454 |
Issue number | 7203 |
DOIs | |
State | Published - Jul 24 2008 |